SCPHARMACEUTICALS INC. Accounts Receivable, Credit Loss Expense (Reversal)
SCPHARMACEUTICALS INC. reported Accounts Receivable, Credit Loss Expense (Reversal) of $57.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-19.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ProvisionForDoubtfulAccounts · last filed 2025-03-19
- SCPHARMACEUTICALS INC. accounts receivable, credit loss expense (reversal) for fiscal 2024 was $57.00K.
| Period end | Accounts Receivable, Credit Loss Expense (Reversal) 12 month |
|---|---|
| 2024-12-31 | $57.00K 10-K · filed 2025-03-19 |